|
TP53INP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.92470000004441E-06 |
| Normal-vs-Stage3 |
1.1474999950245E-08 |
| Normal-vs-Stage4 |
1.30420119148766E-11 |
| Stage1-vs-Stage2 |
5.927000E-01 |
| Stage1-vs-Stage3 |
6.154400E-01 |
| Stage1-vs-Stage4 |
8.445200E-01 |
| Stage2-vs-Stage3 |
9.325000E-01 |
| Stage2-vs-Stage4 |
7.067400E-01 |
| Stage3-vs-Stage4 |
7.532800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
1.07960000050866E-07 |
| Normal-vs-Asian |
7.458700E-03 |
| Caucasian-vs-AfricanAmerican |
3.328400E-01 |
| Caucasian-vs-Asian |
3.420200E-01 |
| AfricanAmerican-vs-Asian |
1.320990E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
9.643800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.03489999999196E-05 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
1.216650E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.643800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.911700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.618600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.743400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.850400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.680800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.99450000000412E-05 |
| Normal-vs-Grade 2 |
<1E-12 |
| Normal-vs-Grade 3 |
<1E-12 |
| Normal-vs-Grade 4 |
1.41370248840644E-11 |
| Grade 1-vs-Grade 2 |
9.639800E-01 |
| Grade 1-vs-Grade 3 |
6.564800E-01 |
| Grade 1-vs-Grade 4 |
6.054000E-01 |
| Grade 2-vs-Grade 3 |
3.765400E-01 |
| Grade 2-vs-Grade 4 |
4.834200E-01 |
| Grade 3-vs-Grade 4 |
1.411170E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.11022302462516E-16 |
| Normal-vs-ccB subtype |
5.6621374255883E-15 |
| ccA subtype-vs-ccB subtype |
7.477700E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
8.08079999999878E-05 |
| N0-vs-N1 |
6.997200E-01 |
|
|
